IGM Biosciences, Inc.
CIK 0001496323
Revenue (TTM)
—
Q2 Jun 2025
Net Income (TTM)
−$64.64M
+20.5% YoY
Q2 Jun 2025
EPS Diluted (TTM)
−$1.08
+31.2% YoY
Q2 Jun 2025
Gross Margin
—
Q2 Jun 2025
Operating Margin
—
Q2 Jun 2025
Net Margin
—
Q2 Jun 2025
Free Cash Flow (TTM)
−$174.25M
Q2 Jun 2025
Cash
$30.65M
Q2 Jun 2025
Total Debt
—
Q2 Jun 2025
Shares Outstanding
25.91M sh
Q2 Jun 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.